About Us

Since 2016, Weill Cornell Medicine (New York) and the Gustave Roussy Cancer Campus (Paris) have joined forces to organize an annual conference that provides a forum for education, discussion, and networking among investigators interested in developing safe and effective RT-IT combinations (ImmunoRad).

Contact Info

Email
christine.corinus

Phone
+33 (0) 1 42 11 53 22

  Gustave Roussy Cancer Campus,
Research Department
Pièce 65 - B2M

 

언어를 선택하세요

Poster session

ImmunoRad Paris 2025

Lorenzo Galluzzi

Weill Cornell Medical College, New York, NY, USA

 

Lorenzo Galluzzi (born 1980) is currently Assistant Professor of Cell Biology in Radiation Oncology with the Department of Radiation Oncology of the Weill Cornell Medical College(New York, NY, USA), and holds many additional appointments with American and European institutions.

Lorenzo Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. In particular, he provided profound insights into the links between adaptive stress responses in cancer cells and the activation of a clinically relevant tumor-targeting immune response in the context of chemotherapy and radiation therapy. Lorenzo Galluzzi has published more than 500 scientific articles in international peer-reviewed journals. He has been consistently nominated Highly Cited Researcher by Clarivate Analytics (formerly, Thomson Reuter) since 2016, often in multiple disciplines in 2016 (Biology)..

Lorenzo Galluzzi also currently operates as Editor-in-Chief of four journals, notably Oncoimmunology, which he co-founded in 2011, and he serves in various Editorial roles for several others.